Sanofi forecasting moderate profit growth Sanofi has forecast moderate earnings growth that undershot expectations, saying demand for bestselling asthma and eczema drug Dupixent would be partly offset by competition for … Business • 03 Feb
Amgen to buy Horizon Therapeutics for $27.8 billion Amgen has today agreed to buy Dublin headquartered Horizon Therapeutics in a deal valued at $27.8 billion, fortifying its rare diseases portfolio amid pressure on … Business • 21 Dec 22
Amgen in advanced talks to buy Horizon Therapeutics Amgen is in advanced talks to buy Dublin headquartered biotech company Horizon Therapeutics, the Wall Street Journal reported today, while rival bidder French health group … Business • 12 Dec 22
Sanofi may bid for Horizon Therapeutics 'in cash' French drugmaker Sanofi fell 2.3% on saying that if it bid for Dublin-headquartered biotech company Horizon Therapeutics, it would do so in cash. Business • 02 Dec 22
Horizon Therapeutics in sale talks with three firms Horizon Therapeutics has said its board is engaged in highly preliminary discussions with three pharmaceutical giants for potential takeover offers, sending its shares surging 31% … Business • 30 Nov 22
GSK, Sanofi, Haleon shares stabilise after Zantac slump Shares in GSK, Sanofi and Haleon began to stabilise today after the companies said that nothing material had changed regarding US litigation focused on heartburn … Business • 12 Aug 22
Sanofi raises 2021 profit guidance again after Q3 beat French drugmaker Sanofi has today again raised its profit guidance for 2021 as its blockbuster eczema drug Dupixent and flu vaccines helped it beat market … Business • 28 Oct 21
Sanofi to invest €400m in a mRNA vaccines facility Sanofi will invest about €400m in research and development of next-generation vaccines using mRNA technologies, which proved their efficiency in the Pfizer and Moderna Covid-19 … Business • 29 Jun 21
Malin completes Kymab sale to Sanofi Malin Corporation has completed the previously announced sale of its investee company Kymab to Sanofi for an upfront payment of approximately $1.1 billion and up … Business • 09 Apr 21
Sanofi eyes more cost cuts to boost profitability Sanofi said today it aimed to grow earnings per share this year after it posted stronger-than-expected results in the fourth quarter, and the drugmaker hiked … Business • 05 Feb 21
Malin Corporation's Kymab to be bought by Sanofi Malin Corporation said its investee immunotherapy company Kymab has been bought by French drugmaker Sanofi in a deal worth up to $1.45 billion. Business • 11 Jan 21
Sanofi sees coronavirus vaccine priced below €10 A coronavirus vaccine that Sanofi is developing with GlaxoSmithKline is likely to be priced at less than €10 per shot if it is approved for … Business • 07 Sep 20
Sanofi halts trial of Covid-19 drug after tests French pharma giant Sanofi said that international Phase 3 clinical tests of its Kevzara drug for serious Covid-19 cases had proved inconclusive and it was … Coronavirus • 01 Sep 20
Sanofi to buy Principia Biopharma for $3.7 billion French healthcare company Sanofi has agreed to buy US company Principia Biopharma for around $3.7 billion, the companies said today. Business • 17 Aug 20
UK secures 60 million doses of Sanofi/GSK vaccine The UK has signed a deal for up to 60 million doses of a possible Covid-19 vaccine being developed by Sanofi and GlaxoSmithKline - its … Business • 29 Jul 20
Calls for inquiry into epilepsy drug sodium valproate A patient group representing families who claim they have been affected by the epilepsy drug, sodium valproate, has called on the Government to commission an … Health • 08 Jul 20
France's Sanofi to cut 1,700 European jobs Pharmaceutical giant Sanofi said today that it would eliminate 1,700 European jobs, including 1,000 in France, as part of a cost-cutting drive announced last December. Business • 26 Jun 20
Sanofi eyes approval of Covid-19 vaccine by H1 2021 French drugmaker Sanofi said today it expects to get approval for the potential Covid-19 vaccine it is developing with Britain's GlaxoSmithKline by the first half … Business • 23 Jun 20
Sanofi turns to Google in search for better treatments French pharmaceutical firm Sanofi said today it is partnering with Google to use artificial intelligence and deep analytics tools to sift through its data to … Business • 18 Jun 19
Germany advises drug makers to examine supply chain German drug makers have been asked by the government to examine their supply chains for any vulnerability that could cause shortages of essential drugs in … Business • 29 Aug 18
Sanofi plans to reshape via $20 billion asset swap Sanofi and Boehringer Ingelheim are in exclusive talks over a $20 billion swap of the French pharmaceuticals company's animal health business for the German group's … Business • 15 Dec 15
€44m investment for Waterford pharmaceutical firm French pharmaceutical company Sanofi is to invest €44 million in the Genzyme biotechnology campus in Co Waterford. Business • 12 Feb 13
